Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia: A Double-Blind, Placebo-Controlled Pilot Trial

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):182-184. doi: 10.1097/JCP.0000000000001012.

Authors

Suat Kucukgoncu¹, Sinan Guloksuz, Cenk Tek

Affiliation

¹ Department of PsychiatryYale UniversityNew Haven, CT [email protected] Department of Psychiatry and Psychology School for Mental Health and Neuroscience Maastricht University Medical Center Maastricht, Netherlands and Department of Psychiatry Yale University New Haven, CT Department of Psychiatry Yale University New Haven, CT.

PMID: 30747752
DOI: 10.1097/JCP.0000000000001012

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adolescent
Adult
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antipsychotic Agents / therapeutic use
Child
Cognition / drug effects*
Curcumin / therapeutic use*
Double-Blind Method
Female
Humans
Male
Middle Aged
Pilot Projects
Schizophrenia / drug therapy
Young Adult

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antipsychotic Agents
Curcumin